Boston Scientific Corporation's BSXMedSurg business group (comprising three sub segments viz. Endoscopy, Urology and Pelvic Health and Neuromodulation) has been recording operational sales growth over the last few quarters. We expect this upside to further find reflection in first-quarter 2018 results, scheduled for release on Apr 25.
Can MedSurg Business Aid Boston Scientific (BSX) Q1 Earnings?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться